SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Ann Lab Med. 2023;43(4):389-391.

In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection.

, , , , , , , ,

제1저자 박정수 · 교신저자 김홍빈

PMID 36843409 PMC9989538 DOI 10.3343/alm.2023.43.4.389 IF 4.4 감염내과
소속 (2)
  1. Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  2. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Figures

Fig. 1
Fig. 1 Pairwise comparisons of antimicrobial activities for all MRSA isolates. Delpazolid potency differences with (A) vancomycin, (B) daptomycin, and (C) linezolid. Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MIC, minimum inhibitory concentration.

그림 출처: PubMed Central 공개 논문 (PMC9989538)

Conflict of interest statement

CONFLICTS OF INTEREST . None declared.

그 밖의 정보
출판 형태
Letter
저널
Annals of laboratory medicine · eISSN 2234-3814
전자 출판
2023-02-24
MeSH
Humans · Methicillin-Resistant Staphylococcus aureus* · Oxazolidinones* / pharmacology · Anti-Bacterial Agents / pharmacology · Sepsis* · Staphylococcal Infections* / diagnosis / drug therapy · Microbial Sensitivity Tests · Cross Infection*
Substances
delpazolid · Oxazolidinones · Anti-Bacterial Agents
참고문헌
8편